Tilmann Burckstummer's Location
Austria
Tilmann Burckstummer's Work
- Chief Executive Officer @ bit.bio discovery
- Chief Scientific Officer @ bit.bio discovery
- Founder and Chief Scientific Officer @ Myllia Biotechnology
- Head of Innovation @ Horizon Discovery
- Director Research and Development @ Horizon Discovery
- Chief Scientific Officer @ Haplogen Genomics GmbH
- Head of Research @ Haplogen GmbH
- Principal Scientist @ Haplogen
- Senior Postdoctoral Fellow @ Österreichische Akademie der Wissenschaften
Tilmann Burckstummer's Education
- Robert Koch Institut
Doctor of Philosophy (PhD) (Virology and Biochemistry)
2001 - 2005 - University of Kansas
Master's degree (Biochemistry, Biophysics and Molecular Biology)
2000 - 2001 - Eberhard-Karls-Universität Tübingen / University of Tuebingen
Bachelor's degree (Vordiplom) (Biochemistry)
1997 - 2000
Tilmann Burckstummer's Skills
- Laboratory
- Cell Biology
- Biochemistry
- Molecular Biology
- Genetics
- Protein Purification
- Cell Culture
- Genomics
- Protein Expression
- Western Blotting
Tilmann Burckstummer's Summary
Tilmann Burckstummer, based in Austria, is currently a Chief Executive Officer at bit.bio discovery, bringing experience from previous roles at bit.bio discovery, Aelian Biotechnology and Horizon Discovery. Tilmann Burckstummer holds a 2001 - 2005 Doctor of Philosophy (PhD) in Virology and Biochemistry @ Robert Koch Institut. With a robust skill set that includes Laboratory, Cell Biology, Biochemistry, Molecular Biology, Genetics and more, Tilmann Burckstummer contributes valuable insights to the industry. Tilmann Burckstummer has 3 emails on RocketReach.
5 free lookups per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Not the Tilmann Burckstummer you were looking for?
Find contact details for 700 million professionals.
People Like Tilmann Burckstummer
-
ViewSimon Rybach
Associate Director Global Business Development and Licensing Consumer Health at Bayer
Cologne, North Rhine-Westphalia, Germany1 -
ViewJoshua Hill
Founder and Owner at Pemberton Whiteman & Hill
Kansas City, Missouri, United States21 -
ViewKatrin Uhlig
Senior Medical Director, Clinical Development, Rare Genetic Diseases at Agios Pharmaceuticals
Boston, Massachusetts, United States12 -
42
-
53
-
24
-
35
-
4
-
5+5
-
25
-
33
-
View
John Ulyshen
Vice President, Program Executive (Auryxia GM) at Akebia Therapeutics
Cambridge, MA, US45+ -
45+
-
52
-
ViewKevin McLaughlin
Senior Vice President and Chief Financial Officer at Acceleron Pharma
Marlborough, MA, US55+ -
View
Dennis France
Senior Director, Scientific Market Development at Pharmaron
Melbourne, Victoria, Australia5+5+ -
35+
-
21
-
41
-
5+2
Top bit.bio discovery Employees
-
25
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups / month.
Search
Search over 700
million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers
(business & personal).
G2Crowd Trusted
300K+
Plugin Users
